Reshape Lifesciences Stock Five Year Return
RSLS Stock | USD 2.49 0.05 2.05% |
Fundamental analysis of ReShape Lifesciences allows traders to better anticipate movements in ReShape Lifesciences' stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. ReShape Lifesciences Company Five Year Return Analysis
ReShape Lifesciences' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, ReShape Lifesciences has a Five Year Return of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
All Next | Launch Module |
ReShape Fundamentals
Return On Equity | -1.2 | ||||
Return On Asset | -0.53 | ||||
Profit Margin | (0.48) % | ||||
Operating Margin | (1.65) % | ||||
Current Valuation | 3.44 M | ||||
Shares Outstanding | 2.39 M | ||||
Shares Owned By Insiders | 10.62 % | ||||
Shares Owned By Institutions | 0.72 % | ||||
Number Of Shares Shorted | 185.34 K | ||||
Price To Book | 4.73 X | ||||
Price To Sales | 0.83 X | ||||
Revenue | 8.01 M | ||||
Gross Profit | 4.57 M | ||||
EBITDA | (6.67 M) | ||||
Net Income | (7.13 M) | ||||
Cash And Equivalents | 11.49 M | ||||
Cash Per Share | 0.51 X | ||||
Total Debt | 967 K | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 2.12 X | ||||
Book Value Per Share | 9.24 X | ||||
Cash Flow From Operations | (4.43 M) | ||||
Short Ratio | 0.50 X | ||||
Earnings Per Share | 264.12 X | ||||
Price To Earnings To Growth | (12.12) X | ||||
Target Price | 1.0 | ||||
Number Of Employees | 17 | ||||
Beta | 1.81 | ||||
Market Capitalization | 5.94 M | ||||
Total Asset | 4.79 M | ||||
Retained Earnings | (642.7 M) | ||||
Working Capital | (397 K) | ||||
Net Asset | 4.79 M |
About ReShape Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ReShape Lifesciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ReShape Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ReShape Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.